| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735207 | Hepatobiliary & Pancreatic Diseases International | 2018 | 6 Pages |
Abstract
Despite the dismal prognosis, partial hepatectomy could prolong the survival of hepatic angiosarcoma patients, particularly those with tumors <10â¯cm. Chemotherapy could be an option for unresectable disease. Liver transplantation is not a recommendable option for the management of this malignancy.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
De-Bang Li, Xiao-Ying Si, Tao Wan, Yan-Ming Zhou,